Literature DB >> 7902316

Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients.

Y M Deugnier1, P Charalambous, D Le Quilleuc, B Turlin, J Searle, P Brissot, L W Powell, J W Halliday.   

Abstract

Sublobular nodules of hepatocytes free of iron or exhibiting much less iron than the surrounding parenchyma, referred to in this study as iron-free-foci, are frequently found in the livers of patients with genetic hemochromatosis complicated by hepatocellular carcinoma. To test the hypothesis that such nodules are preneoplastic lesions, iron-free foci were sought in the initial liver biopsy specimens of 185 patients with untreated and uncomplicated genetic hemochromatosis. Iron-free foci were found in 14 (7.6%) patients, all men, aged from 38 to 76 yr, with heavy iron overload and with fibrosis or cirrhosis. Twelve patients with iron-free foci were followed for 0.9 to 15 yr (7 +/- 6 yr). In six (50%), HCC developed, compared with 2 (8%) from a control group consisting of 24 patients without IFF matched according to age, sex, degree of fibrosis, liver iron amount and follow-up duration. The mean number of iron-free foci per iron-free foci-positive specimen was 3.2 +/- 2.1. Ten patients had dysplastic aspects in their iron-free foci, and four had intrahepatocytic iron-positive inclusions at the periphery of iron-free foci. Proliferative cell nuclear antigen was positive in 75% of iron-free foci and in 24% +/- 21% of hepatocyte nuclei in iron-free foci. This study clearly demonstrates that iron-free foci are proliferative lesions and strongly suggests that such nodules are preneoplastic foci. Therefore the finding of IFF in the initial liver biopsy specimen from a patient with genetic hemochromatosis should lead to regular screening for hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902316

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  26 in total

1.  Nuclear gamma-resonance electron paramagnetic dialysis: implications for experimental biology and medicine.

Authors:  L A Piruzyan; A L Piruzyan
Journal:  Dokl Biol Sci       Date:  2004 Jul-Aug

2.  Effects of sorafenib and cisplatin on preneoplastic foci of altered hepatocytes in fetal turkey liver.

Authors:  Bettina Kaestner; Karsten Spicher; Ulrich Jaehde; Harald Enzmann
Journal:  Toxicol Res (Camb)       Date:  2016-11-02       Impact factor: 3.524

3.  Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.

Authors:  Peter Bannasch
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

4.  Non-invasive methods for liver fibrosis prediction in hemochromatosis: One step beyond.

Authors:  Agustin Castiella; Eva Zapata; José M Alústiza
Journal:  World J Hepatol       Date:  2010-07-27

5.  Hepatocellular carcinoma in African Blacks: Recent progress in etiology and pathogenesis.

Authors:  Michael C Kew
Journal:  World J Hepatol       Date:  2010-02-27

Review 6.  Liver biopsy interpretation for the gastroenterologist.

Authors:  E M Brunt
Journal:  Curr Gastroenterol Rep       Date:  2000-02

7.  Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma.

Authors:  Toshifumi Hoki; Eriko Katsuta; Li Yan; Kazuaki Takabe; Fumito Ito
Journal:  J Surg Res       Date:  2019-02       Impact factor: 2.192

8.  Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications.

Authors:  Hsi-Huang Tseng; Jan-Gowth Chang; Yaw-Huei Hwang; Kun-Tu Yeh; Yao-Li Chen; Hsin-Su Yu
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-23       Impact factor: 4.553

Review 9.  Pathology of hepatic iron overload.

Authors:  Yves Deugnier; Bruno Turlin
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 10.  MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled.

Authors:  Catherine M Greene; Robert B Varley; Matthew W Lawless
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.